Davita Inc (NYSE:DVA) CEO Javier Rodriguez sold 22,532 shares of Davita stock in a transaction that occurred on Thursday, December 7th. The stock was sold at an average price of $67.48, for a total transaction of $1,520,459.36. Following the sale, the chief executive officer now owns 210,317 shares of the company’s stock, valued at approximately $14,192,191.16. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Davita Inc (NYSE:DVA) opened at $71.30 on Thursday. The stock has a market cap of $13,321.91, a P/E ratio of 20.11, a P/E/G ratio of 14.20 and a beta of 0.97. The company has a debt-to-equity ratio of 1.79, a quick ratio of 1.35 and a current ratio of 1.40. Davita Inc has a 1-year low of $52.51 and a 1-year high of $71.44.

Davita (NYSE:DVA) last issued its quarterly earnings data on Tuesday, November 7th. The company reported $0.81 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.94 by ($0.13). The firm had revenue of $3.92 billion for the quarter, compared to analyst estimates of $3.91 billion. Davita had a net margin of 3.40% and a return on equity of 13.31%. The firm’s revenue for the quarter was up 5.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.95 EPS. equities analysts forecast that Davita Inc will post 3.42 EPS for the current year.

Davita declared that its Board of Directors has initiated a share buyback plan on Tuesday, October 10th that permits the company to buyback $1.50 billion in shares. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s board believes its shares are undervalued.

A number of hedge funds and other institutional investors have recently modified their holdings of DVA. Canada Pension Plan Investment Board grew its holdings in Davita by 33.1% during the second quarter. Canada Pension Plan Investment Board now owns 387,370 shares of the company’s stock valued at $25,086,000 after purchasing an additional 96,282 shares during the period. Pzena Investment Management LLC lifted its stake in Davita by 2.1% in the second quarter. Pzena Investment Management LLC now owns 3,398 shares of the company’s stock valued at $220,000 after buying an additional 71 shares in the last quarter. Airain ltd bought a new position in Davita in the second quarter valued at approximately $2,234,000. Jensen Investment Management Inc. lifted its stake in Davita by 24.2% in the second quarter. Jensen Investment Management Inc. now owns 9,740 shares of the company’s stock valued at $631,000 after buying an additional 1,900 shares in the last quarter. Finally, Schroder Investment Management Group lifted its stake in Davita by 53.9% in the second quarter. Schroder Investment Management Group now owns 49,967 shares of the company’s stock valued at $3,201,000 after buying an additional 17,497 shares in the last quarter. Hedge funds and other institutional investors own 85.32% of the company’s stock.

Several brokerages have recently commented on DVA. Robert W. Baird upgraded shares of Davita from a “neutral” rating to an “outperform” rating and lifted their price target for the stock from $63.00 to $82.00 in a research report on Tuesday. SunTrust Banks set a $70.00 price target on shares of Davita and gave the stock a “hold” rating in a research report on Thursday, December 7th. Raymond James Financial upgraded shares of Davita from an “outperform” rating to a “strong-buy” rating and lifted their price target for the stock from $65.00 to $84.00 in a research report on Thursday, December 7th. J P Morgan Chase & Co lifted their price target on shares of Davita from $4.90 to $84.00 and gave the stock a “strong-buy” rating in a research report on Thursday, December 7th. Finally, Citigroup upgraded shares of Davita from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $67.71 to $82.00 in a research report on Monday. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating, three have assigned a buy rating and two have issued a strong buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $73.33.

ILLEGAL ACTIVITY NOTICE: “Insider Selling: Davita Inc (DVA) CEO Sells $1,520,459.36 in Stock” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/12/14/insider-selling-davita-inc-dva-ceo-sells-1520459-36-in-stock.html.

About Davita

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Insider Buying and Selling by Quarter for Davita (NYSE:DVA)

Receive News & Stock Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related stocks with our FREE daily email newsletter.